Global Information
회사소개 | 문의 | 비교리스트

세계의 심혈관계 의약품 시장

Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

리서치사 The Business Research Company
발행일 2020년 05월 상품 코드 531324
페이지 정보 영문
가격
US $ 4,000 ₩ 5,010,000 PDF by E-mail (Single User License)
US $ 6,000 ₩ 7,515,000 PDF by E-mail (Site License)
US $ 8,000 ₩ 10,020,000 PDF by E-mail (Enterprise License)


세계의 심혈관계 의약품 시장 Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
발행일 : 2020년 05월 페이지 정보 : 영문

세계의 심혈관계 의약품(Cardiovascular Drugs) 시장을 조사했으며, 시장의 정의와 개요, 시장에 대한 각종 영향요인 분석, 질환 분류·지역·국가별 동향과 시장 규모의 추이와 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 심혈관계 의약품 시장 분석 : 분류별

  • 세계 시장의 실적 : 분류별
    • 고혈압 치료제
    • 지질 강하약
    • 항혈전약
    • 기타
      • 혈성 심부전
      • 항부정맥약
      • 협심증 치료제
  • 세계 시장의 추이와 예측 : 분류별
  • 시장 동향·전략

제6장 심혈관계 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 분류·지역별
  • 세계 의약품 시장의 실적 : 분류·국가별

제7장 거시경제 요인과 시장 비교

  • 시장 규모에서 GDP가 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장 비교 : 국가별

  • 시장 규모에서 GDP가 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품 회사 수 : 국가별
  • 시장 매출 vs 의약품 회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 판매 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 판매 비율 : 국가별
  • 세계의 일반 개업의 수 : 국가별
  • 시장 매출 vs 일반 개업의 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 분류별

제17장 경쟁 환경

  • 기업 개요
  • Johnson & Johnson
  • Novartis Ag
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi

제18장 주요 M&A

제19장 시장 배경 : 심혈관계 의약품 시장

제20장 헬스케어 산업의 파이낸셜 마진

제21장 부록

KSA 20.03.11

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

‘Cardiovascular Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cardiovascular drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cardiovascular drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cardiovascular drugs market section of the report gives context. It compares the cardiovascular drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cardiovascular drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Merck & Co; Sanofi S.A; Pfizer Inc; Bristol-Myers Squibb Company; Novartis AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Cardiovascular Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Cardiovascular Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Cardiovascular Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Cardiovascular Drugs Market Trends And Strategies

8. Cardiovascular Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Cardiovascular Drugs Market Regional Analysis

  • 9.1. Global Cardiovascular Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

10. Cardiovascular Drugs Market Segmentation

  • 10.1. Global Cardiovascular Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti-Hypertensive Drugs

Hypolipidemics

Anti Thrombotics

Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

  • 10.2. Global Cardiovascular Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Cardiovascular Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Cardiovascular Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Cardiovascular Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Cardiovascular Drugs Market Metrics

  • 11.1. Cardiovascular Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Cardiovascular Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Cardiovascular Drugs Market

  • 12.1. Asia-Pacific Cardiovascular Drugs Market Overview
  • 12.2. Asia-Pacific, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Cardiovascular Drugs Market Metrics
    • 12.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • 12.6. Asia-Pacific Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Cardiovascular Drugs Market: Country Analysis
    • 12.7.1. China Cardiovascular Drugs Market
      • 12.7.1.1. China Cardiovascular Drugs Market Overview
      • 12.7.1.2. China Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Cardiovascular Drugs Market
      • 12.7.2.1. Australia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Cardiovascular Drugs Market
      • 12.7.3.1. Hong Kong Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Cardiovascular Drugs Market
      • 12.7.4.1. India Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Cardiovascular Drugs Market
      • 12.7.5.1. Indonesia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Cardiovascular Drugs Market
      • 12.7.6.1. Japan Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Cardiovascular Drugs Market
      • 12.7.7.1. Malaysia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Cardiovascular Drugs Market
      • 12.7.8.1. New Zealand Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Cardiovascular Drugs Market
      • 12.7.9.1. Philippines Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Cardiovascular Drugs Market
      • 12.7.10.1. Singapore Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Cardiovascular Drugs Market
      • 12.7.11.1. South Korea Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Cardiovascular Drugs Market
      • 12.7.12.1. Thailand Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Cardiovascular Drugs Market
      • 12.7.13.1. Vietnam Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Cardiovascular Drugs Market

  • 13.1. Western Europe Cardiovascular Drugs Market Overview
  • 13.2. Western Europe, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Cardiovascular Drugs Market Metrics
    • 13.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Western Europe Countries
  • 13.6. Western Europe Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Cardiovascular Drugs Market: Country Analysis
    • 13.7.1. Austria Cardiovascular Drugs Market
      • 13.7.1.1. Austria Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Cardiovascular Drugs Market
      • 13.7.2.1. Belgium Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Cardiovascular Drugs Market
      • 13.7.3.1. Denmark Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Cardiovascular Drugs Market
      • 13.7.4.1. Finland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Cardiovascular Drugs Market
      • 13.7.5.1. France Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Cardiovascular Drugs Market
      • 13.7.6.1. Germany Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Cardiovascular Drugs Market
      • 13.7.7.1. Ireland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Cardiovascular Drugs Market
      • 13.7.8.1. Italy Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Cardiovascular Drugs Market
      • 13.7.9.1. Netherlands Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Cardiovascular Drugs Market
      • 13.7.10.1. Norway Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Cardiovascular Drugs Market
      • 13.7.11.1. Portugal Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Cardiovascular Drugs Market
      • 13.7.12.1. Spain Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Cardiovascular Drugs Market
      • 13.7.13.1. Sweden Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Cardiovascular Drugs Market
      • 13.7.14.1. Switzerland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Cardiovascular Drugs Market
      • 13.7.15.1. UK Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Cardiovascular Drugs Market

  • 14.1. Eastern Europe Cardiovascular Drugs Market Overview
  • 14.2. Eastern Europe, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Cardiovascular Drugs Market Metrics
    • 14.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • 14.6. Eastern Europe Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Cardiovascular Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Cardiovascular Drugs Market,
      • 14.7.1.1. Czech Republic Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Cardiovascular Drugs Market
      • 14.7.2.1. Poland Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Cardiovascular Drugs Market
      • 14.7.3.1. Romania Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Cardiovascular Drugs Market
      • 14.7.4.1. Russia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Cardiovascular Drugs Market

  • 15.1. North America Cardiovascular Drugs Market Overview
  • 15.2. North America, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Cardiovascular Drugs Market Metrics
    • 15.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, North America Countries
  • 15.6. North America Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Cardiovascular Drugs Market: Country Analysis
    • 15.7.1. Canada Cardiovascular Drugs Market
      • 15.7.1.1. Canada Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Cardiovascular Drugs Market
      • 15.7.2.1. Mexico Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Cardiovascular Drugs Market
      • 15.7.3.1. USA Cardiovascular Drugs Market Overview
      • 15.7.3.2. USA Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Cardiovascular Drugs Market

  • 16.1. South America Cardiovascular Drugs Market Overview
  • 16.2. South America, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Cardiovascular Drugs Market Metrics
    • 16.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, South America Countries
  • 16.6. South America Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Cardiovascular Drugs Market: Country Analysis
    • 16.7.1. Argentina Cardiovascular Drugs Market
      • 16.7.1.1. Argentina Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Cardiovascular Drugs Market
      • 16.7.1.1. Brazil Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Cardiovascular Drugs Market
      • 16.7.3.1. Chile Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Cardiovascular Drugs Market
      • 16.7.4.1. Colombia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Cardiovascular Drugs Market
      • 16.7.5.1. Peru Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Cardiovascular Drugs Market
      • 16.7.6.1. Venezuela Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Cardiovascular Drugs Market

  • 17.1. Middle East Cardiovascular Drugs Market Overview
  • 17.2. Middle East, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Cardiovascular Drugs Market Metrics
    • 17.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Middle East Countries
  • 17.6. Middle East Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Cardiovascular Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Cardiovascular Drugs Market
      • 17.7.1.1. Saudi Arabia Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Cardiovascular Drugs Market
      • 17.7.2.1. Israel Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Cardiovascular Drugs Market
      • 17.7.3.1. Turkey Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Cardiovascular Drugs Market
      • 17.7.4.1. UAE Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Cardiovascular Drugs Market

  • 18.1. Africa Cardiovascular Drugs Market Overview
  • 18.2. Africa, Cardiovascular Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Cardiovascular Drugs Market Metrics
    • 18.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2015-2023, Africa Countries
  • 18.6. Africa Cardiovascular Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Cardiovascular Drugs Market: Country Analysis
    • 18.7.1. Egypt Cardiovascular Drugs Market
      • 18.7.1.1. Egypt Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Cardiovascular Drugs Market
      • 18.7.2.1. Nigeria Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Cardiovascular Drugs Market
      • 18.7.3.1. South Africa Cardiovascular Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Cardiovascular Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Merck & Co
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. Sanofi S.A
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Pfizer Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Bristol-Myers Squibb Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Cardiovascular Drugs Market In 2023- Growth Countries
  • 22.2. Global Cardiovascular Drugs Market In 2023- Growth Segments
  • 22.3. Global Cardiovascular Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top
전화 문의
F A Q